Know Cancer

or
forgot password

Molecular and Cytogenetic Studies of Ocular Melanoma


N/A
18 Years
N/A
Open (Enrolling)
Both
Choroidal Melanoma

Thank you

Trial Information

Molecular and Cytogenetic Studies of Ocular Melanoma


The Jules Stein Eye Institute Ocular Melanoma Research Group is conducting cytogenetic
studies of choroidal melanoma to improve the screening of biopsy samples of choroidal
melanoma through cytogenetic analysis. Our goal is to identify molecular probes that
specifically target regions of chromosomes that undergo changes characteristic of metastatic
choroidal melanoma.


Inclusion Criteria:



1. Patient with diagnosis of ocular melanoma

2. Patient with local treatment plan for ocular melanoma- plaque brachytherapy or
enucleation

3. Patient 18 years of age or older

4. Archival enucleation specimens with diagnosis of ocular melanoma

Exclusion Criteria:

1. Patient who refuses local melanoma treatment

2. Patient who refuses to participate in this study

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Tara M McCannel, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Jules Stein Eye Institute, UCLA

Authority:

United States: Institutional Review Board

Study ID:

UCLA IRB#04-12-084

NCT ID:

NCT00344799

Start Date:

April 2005

Completion Date:

Related Keywords:

  • Choroidal Melanoma
  • Choroidal Melanoma
  • Choroidal Malignant Melanoma
  • Ocular Melanoma
  • Uveal Melanoma
  • Melanoma

Name

Location

Jules Stein Eye InstituteLos Angeles, California  90095